3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
5
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Neoplasms, Unknown Primary
2
Lung Neoplasms
2
Carcinoma
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Unresectable Stage III NSCLC
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Penile Neoplasms
1
Pathologic Complete Response
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Male Urogenital Diseases
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
First-line Advanced NSCLC Patients
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Endocrine System Diseases
1
Interventions
Cisplatin
139
pembrolizumab
88
Carboplatin
73
Radiotherapy
71
Cetuximab
69
Docetaxel
58
Paclitaxel
52
Radiotherapy, Intensity-Modulated
43
Fluorouracil
43
Nivolumab
32
Surgical Procedures, Operative
18
Albumin-Bound Paclitaxel
15
130-nm albumin-bound paclitaxel
15
Radiation
14
Drug Therapy
14
tislelizumab
13
Taxes
13
durvalumab
12
Magnetic Resonance Spectroscopy
12
toripalimab
11
camrelizumab
11
Platinum
11
Chemoradiotherapy
11
Biopsy
11
cemiplimab
10
Radiosurgery
10
Erlotinib Hydrochloride
10
Capecitabine
10
Specimen Handling
9
Neoadjuvant Therapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Squamous Cell Carcinoma of Head and Neck
×
CP protocol
×
Clear all
NCT05294900
2026-05-26
NEOS
Yonsei University
Phase 2
Completed
79 enrolled
6 charts